BioCentury | Jan 14, 2021
Finance

With €127M series B, cancer vaccine developer IO Biotech raises second-largest European venture round in the past year

...Seeds Bristol Myers Squibb Co. Novo Holdings A/S Vivo Capital Kurma Partners Avoro Capital Advisors RA Capital Management Samsara BioCapital Idinvest Partners Soleus Capital Eir Ventures Lundbeckfond Emerge Sunstone...
BioCentury | Mar 21, 2020
Product Development

Under duress, biotechs will have to make hard decisions for patients and themselves about which trials to run

...SERPINA1) - α-1 antitrypsin Karen Tkach Tuzman, Associate Editor Sofinnova Ventures Sofinnova Partners Synlogic Inc. Genenta Science s.r.l. Forbion Capital Partners Cerevance Inc. Lundbeckfond Emerge Scynexis...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Pharma ApS Aarhus, Denmark $46.6 INKEF Capital , Roche Venture Fund , Novo Seeds , Lundbeckfond Emerge...
BioCentury | Nov 30, 2018
Emerging Company Profile

Afyx: Mucosal drug delivery

...Sheffield Corporate partners: N/A Number of employees: 11 Funds raised: $20 million Investors: Sofinnova Ventures, Lundbeckfond Emerge...
BioCentury | Mar 23, 2018
Financial News

Neuromuscular play NMD raises EUR38M in series A

...candidates to Phase II within three to four years. NMD Pharma ApS, Aarhus, Denmark Allison Johnson INKEF Capital Lundbeckfond Emerge NMD...
BioCentury | Aug 22, 2016
Finance

Northern Lights 2.0

...or II testing. In 2012, the foundation went further upstream with the formation of its Lundbeckfond Emerge...
...million per year. "The critical mass is much more in place now in Denmark," said Lundbeckfond Emerge's...
...an undisclosed sum in 2009. He also is a co-founder of Insusense Therapeutics ApS, a Lundbeckfond Emerge...
BioCentury | Jun 23, 2016
Emerging Company Profile

Boosting transmission

...Nielsen and Claus OlesenUniversity collaborators: Aarhus UniversityCorporate partners: NoneNumber of employees: 10Funds raised: $3 millionInvestors: Lundbeckfond Emerge...
BioCentury | Jun 20, 2016
Financial News

NMD Pharma completes venture financing

...Aarhus, Denmark Business: Neurology Date completed: 2016-06-13 Type: Venture financing Raised: $3 million Investors: Lundbeckfond Emerge...
BioCentury | Feb 1, 2016
Finance

Emerging in Denmark

...Lundbeck Foundation wants to ramp up its early stage investing. The group has tasked its Lundbeckfond Emerge...
...the trust decided they wanted a unit that focuses selectively on early stage investments," said Lundbeckfond Emerge's...
...have yet reached that point, according to Elling. To test the waters, the board told Lundbeckfond Emerge...
BioCentury | Jan 11, 2016
Financial News

IO Biotech completes venture financing

...Denmark Business: Cancer Date completed: 2016-01-05 Type: Venture financing Raised: EUR11 million ($12 million) Investors: Lundbeckfond Emerge...
Items per page:
1 - 10 of 15
BioCentury | Jan 14, 2021
Finance

With €127M series B, cancer vaccine developer IO Biotech raises second-largest European venture round in the past year

...Seeds Bristol Myers Squibb Co. Novo Holdings A/S Vivo Capital Kurma Partners Avoro Capital Advisors RA Capital Management Samsara BioCapital Idinvest Partners Soleus Capital Eir Ventures Lundbeckfond Emerge Sunstone...
BioCentury | Mar 21, 2020
Product Development

Under duress, biotechs will have to make hard decisions for patients and themselves about which trials to run

...SERPINA1) - α-1 antitrypsin Karen Tkach Tuzman, Associate Editor Sofinnova Ventures Sofinnova Partners Synlogic Inc. Genenta Science s.r.l. Forbion Capital Partners Cerevance Inc. Lundbeckfond Emerge Scynexis...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Pharma ApS Aarhus, Denmark $46.6 INKEF Capital , Roche Venture Fund , Novo Seeds , Lundbeckfond Emerge...
BioCentury | Nov 30, 2018
Emerging Company Profile

Afyx: Mucosal drug delivery

...Sheffield Corporate partners: N/A Number of employees: 11 Funds raised: $20 million Investors: Sofinnova Ventures, Lundbeckfond Emerge...
BioCentury | Mar 23, 2018
Financial News

Neuromuscular play NMD raises EUR38M in series A

...candidates to Phase II within three to four years. NMD Pharma ApS, Aarhus, Denmark Allison Johnson INKEF Capital Lundbeckfond Emerge NMD...
BioCentury | Aug 22, 2016
Finance

Northern Lights 2.0

...or II testing. In 2012, the foundation went further upstream with the formation of its Lundbeckfond Emerge...
...million per year. "The critical mass is much more in place now in Denmark," said Lundbeckfond Emerge's...
...an undisclosed sum in 2009. He also is a co-founder of Insusense Therapeutics ApS, a Lundbeckfond Emerge...
BioCentury | Jun 23, 2016
Emerging Company Profile

Boosting transmission

...Nielsen and Claus OlesenUniversity collaborators: Aarhus UniversityCorporate partners: NoneNumber of employees: 10Funds raised: $3 millionInvestors: Lundbeckfond Emerge...
BioCentury | Jun 20, 2016
Financial News

NMD Pharma completes venture financing

...Aarhus, Denmark Business: Neurology Date completed: 2016-06-13 Type: Venture financing Raised: $3 million Investors: Lundbeckfond Emerge...
BioCentury | Feb 1, 2016
Finance

Emerging in Denmark

...Lundbeck Foundation wants to ramp up its early stage investing. The group has tasked its Lundbeckfond Emerge...
...the trust decided they wanted a unit that focuses selectively on early stage investments," said Lundbeckfond Emerge's...
...have yet reached that point, according to Elling. To test the waters, the board told Lundbeckfond Emerge...
BioCentury | Jan 11, 2016
Financial News

IO Biotech completes venture financing

...Denmark Business: Cancer Date completed: 2016-01-05 Type: Venture financing Raised: EUR11 million ($12 million) Investors: Lundbeckfond Emerge...
Items per page:
1 - 10 of 15